Exelixis, Inc. (EXEL)

44.25 +0.19 (+0.43%) USD  |  NASDAQ  |  Jan 13, 14:32
More

Exelixis Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for EXEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Natera, Inc. Upgrade
Merck & Co., Inc. Upgrade